TP53 and head and neck squamous cell carcinoma: The study showed how numerous research studies have examined various p53 reactivators to provide a solution to the demand for novel treatment regimens in HNSCC because personalized medicine is an efficient and better way of therapy that must be improved before being applied clinically.